Table 1. Routes, timelines and therapeutic doses in different groups.
Groups | Route of injection | Amount of injection | Number of injection | Duration of treatment |
---|---|---|---|---|
G1 (Folded HNP1) | s.c.* | 30μg/mouse | Once a week | Three weeks |
G2 (pcDNA-HNP1-EGFP) | s.c. | 50μg/50μl | Twice a week | Three weeks |
G3 (pcDNA- EGFP) | s.c. | 50μg/50μl | Twice a week | Three weeks |
G4 (AmB) | i.p.** | 8mg/kg | 10 days | 10 days |
G5 (PBS | s.c. | 50 μl | Twice a week | Three weeks |
*s.c: sub cutaneous
**i.p: intra peritoneal